On Friday, Alx Oncology Holdings Inc (NASDAQ: ALXO) was 9.30% up from the session before settling in for the closing price of $1.29. A 52-week range for ALXO has been $1.19 – $17.83.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -8.67%. When this article was written, the company’s average yearly earnings per share was at 26.31%. With a float of $34.33 million, this company’s outstanding shares have now reached $49.95 million.
Let’s determine the extent of company efficiency that accounts for 72 employees. In terms of profitability, gross margin is 74.15%, operating margin of -6446.65%, and the pretax margin is -6095.12%.
Alx Oncology Holdings Inc (ALXO) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Alx Oncology Holdings Inc stocks. The insider ownership of Alx Oncology Holdings Inc is 34.91%, while institutional ownership is 58.46%. The most recent insider transaction that took place on Aug 14 ’24, was worth 1,455. In this transaction SVP, FINANCE AND CAO of this company sold 564 shares at a rate of $2.58, taking the stock ownership to the 91,549 shares. Before that another transaction happened on Aug 14 ’24, when Company’s CHIEF MEDICAL OFFICER sold 1,365 for $2.58, making the entire transaction worth $3,522. This insider now owns 325,711 shares in total.
Alx Oncology Holdings Inc (ALXO) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.79 earnings per share (EPS) during the time that was better than consensus figure (set at -0.84) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.82 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 26.31% per share during the next fiscal year.
Alx Oncology Holdings Inc (NASDAQ: ALXO) Trading Performance Indicators
You can see what Alx Oncology Holdings Inc (ALXO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.98, a number that is poised to hit -0.67 in the next quarter and is forecasted to reach -2.50 in one year’s time.
Technical Analysis of Alx Oncology Holdings Inc (ALXO)
Looking closely at Alx Oncology Holdings Inc (NASDAQ: ALXO), its last 5-days average volume was 0.92 million, which is a jump from its year-to-date volume of 0.78 million. As of the previous 9 days, the stock’s Stochastic %D was 33.83%. Additionally, its Average True Range was 0.12.
During the past 100 days, Alx Oncology Holdings Inc’s (ALXO) raw stochastic average was set at 2.90%, which indicates a significant decrease from 50.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 71.93% in the past 14 days, which was lower than the 119.09% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6017, while its 200-day Moving Average is $7.7154. However, in the short run, Alx Oncology Holdings Inc’s stock first resistance to watch stands at $1.4767. Second resistance stands at $1.5433. The third major resistance level sits at $1.6467. If the price goes on to break the first support level at $1.3067, it is likely to go to the next support level at $1.2033. Now, if the price goes above the second support level, the third support stands at $1.1367.
Alx Oncology Holdings Inc (NASDAQ: ALXO) Key Stats
There are 52,743K outstanding shares of the company, which has a market capitalization of 81.29 million. As of now, sales total 0 K while income totals -160,810 K. Its latest quarter income was 0 K while its last quarter net income were -30,710 K.
